Susanne Rhoades has extensive work experience in the field of diagnostic development. Susanne started their career as a Postdoctoral Fellow at the Huntsman Cancer Institute University of Utah in 1999. In 2004, they joined Eli Lilly and Company as a Sr. Clinical Development Associate and later held roles as a Consultant Clinical Project Management and Advisor in In Vitro Diagnostic Development. In 2020, they joined Loxo Oncology at Lilly and has since held positions as Director, Senior Director, and currently as Associate Vice President in Diagnostic Development.
Susanne Rhoades completed their Bachelor of Science in Pharmacy from Purdue University from 1988 to 1993. Later, they pursued a Doctor of Philosophy in Pharmacology from Vanderbilt University School of Medicine from 1993 to 1998.
January, 2023 - present
September, 2021
September, 2020